CLINICAL_TRIALS
trial_result
· 2020-12-17
Clinical Trial Update: Antidote for Valproic Acid Toxicity: a New Indication for Meropenem Antibiotic. [Phase 4]
Summary
Phase 4 clinical trial update exploring meropenem as an antidote for valproic acid toxicity.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mabaret Al-Asafara Hospitals | Conditions: Drug Toxicity | Phase 4 | Status: UNKNOWN